Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Sabra Healthcare REIT ( (SBRA) ) has shared an announcement.
In the first quarter of 2025, Sabra Healthcare REIT reported a net income of $0.17 per diluted share and continued to see growth in its senior housing managed portfolio, with a 16.9% increase in same-store cash NOI. The company exercised its option to acquire additional senior housing assets and was awarded over $200 million in new acquisition opportunities, reflecting its strategic focus on expanding its portfolio. Sabra’s liquidity position remains strong with $1.1 billion available, and Fitch Ratings affirmed its ‘BBB-‘ credit rating with a stable outlook, indicating confidence in its financial stability and growth prospects.
Spark’s Take on SBRA Stock
According to Spark, TipRanks’ AI Analyst, SBRA is a Neutral.
Sabra Healthcare REIT’s overall stock score reflects its moderate financial performance, strong cash flows, and positive earnings guidance. While operational efficiency and leverage pose some risks, the company’s robust dividend yield and neutral technical indicators provide a balanced outlook. The positive sentiment from the earnings call, highlighting growth opportunities and a solid balance sheet, further supports the score.
To see Spark’s full report on SBRA stock, click here.
More about Sabra Healthcare REIT
Sabra Healthcare REIT, Inc. operates in the real estate investment trust (REIT) sector, focusing on healthcare properties. Its portfolio includes skilled nursing facilities, senior housing communities, behavioral health facilities, and specialty hospitals across the United States and Canada.
YTD Price Performance: 2.42%
Average Trading Volume: 2,539,532
Technical Sentiment Signal: Strong Sell
Current Market Cap: $4.14B
Learn more about SBRA stock on TipRanks’ Stock Analysis page.